Margherita joined the OHE in December 2016 as Economist. Her work at the OHE has involved a number consulting projects, relating to different aspects of pharmaceutical R&D and HTA activities. She has experience in supporting the development of internal strategies for pharmaceutical companies in defining the value proposition of their pipeline (e.g. value frameworks) and the evidence generation processes during the product lifecycle. She has also collaborated in studying the evolution the HTA paradigm, given the challenges and limitations faced by current approaches. Margherita has undertaken analytical work on and is interested in the incentives for R&D in the area of personalised medicines. Currently, she is involved in a project to understand the medicine market and the performance of the pharmaceutical industry in the UK.
Margherita’s research interests include the economic evaluation of health care policies, the incentives to optimise demand and supply of health care, as well as aspects of competition in health care and pharmaceutical markets.
Margherita joined the Office of Health Economics after completing her MSc in Economics at University College London (UCL). Her MSc dissertation analysed the effect of a reform of the Italian health care market. More specifically, she analysed the effects of more demanding cost-sharing instruments aimed to the control of the demand for outpatient care. Prior to that Margherita pursued her undergraduate degree in Economics and Statistics at the University of Siena (Italy) including a year spent as a visiting student at the University of Oxford.